“A Biology-Driven Multi-Chamber Device For Culturing 3D Tissues And Performing Reliable Absorption Assays” and “3D Human Cancer Models Within The MIVO- Multi In Vitro Organ Fluidic Device For Improving The Outcome Of In Vitro Drug Testing” are the titles of our poster on Oxofrod Global today.
We are proud to be here to present our Organ on chip technology for the discovery of drugs in new ways in the discovery of biotherapies, proteins, cells and genetic bases.
The purpose of this event is to present the pharma world and discover the latest updates on the integration of screening approaches in phenotypic and genomic-based discovery, on-chip organ and 3D modeling, RNA as new pharmacological targets
Insights into drug discovery strategies and next generation therapies, enhancing drug discovery with chemical biology, goal validation, drug profiling and protein degradation technologies
Explore successful strategies in the development of compound libraries, DNA / RNA coded library, protein-protein interaction, fragmentation and design of structured drugs
Focus on cutting-edge tools, including; AI in ADME, big data management, model management, artificial intelligence, machine learning in drug design and AI in chemical synthesis, AI-enabled target ID capabilities, identification / optimization of leads.
https://www.oxfordglobal.co.uk/discovery-series-virtual/agenda/
What theme will we address during the meeting:
At 10:30 AM Maurizio Aiello will deal with the following topic “A Biology-Driven Multi-Chamber Device For Culturing 3D Tissues And Performing Reliable Absorption Assays” while at 12AM it will be Silvia Scaglione’s turn with “3D Human Cancer Models Within The # MIVO- Multi In Vitro Organ Fluidic Device For Improving The Outcome Of In Vitro Drug Testing ”